Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
32.32
-0.37 (-1.13%)
Feb 21, 2025, 4:00 PM EST - Market closed
Ionis Pharmaceuticals Revenue by Product
History
| Date | Spinraza | Wainua | Tegsedi and Waylivra |
|---|---|---|---|
| Dec 31, 2024 | 216.41M | 20.28M | 33.74M |
| Sep 30, 2024 | 214.41M | 10.28M | 34.74M |
| Jun 30, 2024 | 224.45M | 4.91M | 34.11M |
| Mar 31, 2024 | 228.72M | 1.13M | 36.57M |
| Dec 31, 2023 | 240.51M | - | 34.42M |
| Sep 30, 2023 | 245.51M | - | 32.42M |
| Jun 30, 2023 | 239.91M | - | 30.05M |
| Mar 31, 2023 | 238.52M | - | 29.78M |
| Dec 31, 2022 | 242.09M | - | 29.47M |
| Sep 30, 2022 | 244.09M | - | 31.47M |
| Jun 30, 2022 | 249.02M | - | 41.07M |
| Mar 31, 2022 | 261.56M | - | 42.22M |
| Dec 31, 2021 | 267.73M | - | 55.90M |
| Sep 30, 2021 | 273.73M | - | 65.90M |
| Jun 30, 2021 | 281.15M | - | 69.38M |
| Mar 31, 2021 | 280.99M | - | 73.84M |
| Dec 31, 2020 | 287.00M | - | 69.00M |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.